Wed, November 24, 2021
Tue, November 23, 2021
Mon, November 22, 2021
Sun, November 21, 2021
Sat, November 20, 2021
Fri, November 19, 2021
Thu, November 18, 2021
Wed, November 17, 2021
Tue, November 16, 2021

Evan Seigerman Initiated (CADL) at Buy and Held Target at $18 on, Nov 19th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-18-on-nov-19th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Evan Seigerman of BMO Capital, Initiated "Candel Therapeutics, Inc." (CADL) at Buy and Held Target at $18 on, Nov 19th, 2021.

Evan has made no other calls on CADL in the last 4 months.



There are 3 other peers that have a rating on CADL. Out of the 3 peers that are also analyzing CADL, 0 agree with Evan's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Evan


  • Chris Howerton of "Jefferies" Initiated at Strong Buy and Held Target at $22 on, Monday, August 23rd, 2021
  • Colin Bristow of "UBS" Initiated at Strong Buy and Held Target at $9 on, Monday, August 23rd, 2021
  • Judah Frommer of "Credit Suisse" Initiated at Buy and Held Target at $15 on, Monday, August 23rd, 2021

Publication Contributing Sources